Mobile Phone-Based Microscopes Diagnose Intestinal Parasites
|
By LabMedica International staff writers Posted on 13 Jul 2016 |

Image: Handheld- and mobile phone-based microscopes: A) The Newton Nm1-600 XY portable field microscope B) The reversed-lens CellScope attached to an iPhone 5s (Photo courtesy of University Health Network).
Handheld, mobile phone-based microscopes can be used in developing countries after minimal training of community laboratory technicians to diagnose intestinal parasites quickly and accurately.
Intestinal worms affect almost two billion people world-wide, predominantly in areas with poor sanitation and unsafe water and in children, these parasites may lead to malnutrition, stunted growth and development and can lead to chronic disability, with serious health and economic consequences.
An international team of scientists led by those at the University of Toronto (ON, Canada) trained local laboratory technicians to operate the two handheld microscopes. In total, the technicians examined stool and urine samples from 226 individuals for the detection of parasites. The accuracy of all slides was evaluated by all microscopes: the two handheld devices, as well as a conventional, “gold standard” microscope.
The two portable handheld microscopes:tested were a commercial Newton Nm1 microscope (Newton Microscopes, Bedford, UK) and a mobile phone-based CellScope (CellScope Inc, San Francisco, CA, USA) which is essentially a smartphone with a special custom-fitted lens attached over the camera and light source, developed by engineers, to detect intestinal parasites. Slides were first evaluated using an Olympus CX21 microscope (Volketswil, Switzerland) as the gold standard.
The scientists reported that the two handheld microscopes were very good at ruling in infections, and the Newton portable microscope was able to detect even very low-burden infections. The CellScope missed some low-burden infections, however newer iterations of this device are currently being tested to increase its sensitivity.
Isaac I. Bogoch, MD, the lead investigator said, “It was heart-warming to see how well and easily these portable, handheld field microscopes were adopted and used in a rural setting. This will help us map out the areas of greatest need. Novel diagnostic approaches for common parasitic infections could have a profound impact on care of patients, as well as on public health approaches to screening in resource-poor areas.” The study was published on June 27, 2016, in the journal PLOS Neglected Tropical Diseases.
Related Links:
University of Toronto
Newton Microscopes
CellScope
Olympus
Intestinal worms affect almost two billion people world-wide, predominantly in areas with poor sanitation and unsafe water and in children, these parasites may lead to malnutrition, stunted growth and development and can lead to chronic disability, with serious health and economic consequences.
An international team of scientists led by those at the University of Toronto (ON, Canada) trained local laboratory technicians to operate the two handheld microscopes. In total, the technicians examined stool and urine samples from 226 individuals for the detection of parasites. The accuracy of all slides was evaluated by all microscopes: the two handheld devices, as well as a conventional, “gold standard” microscope.
The two portable handheld microscopes:tested were a commercial Newton Nm1 microscope (Newton Microscopes, Bedford, UK) and a mobile phone-based CellScope (CellScope Inc, San Francisco, CA, USA) which is essentially a smartphone with a special custom-fitted lens attached over the camera and light source, developed by engineers, to detect intestinal parasites. Slides were first evaluated using an Olympus CX21 microscope (Volketswil, Switzerland) as the gold standard.
The scientists reported that the two handheld microscopes were very good at ruling in infections, and the Newton portable microscope was able to detect even very low-burden infections. The CellScope missed some low-burden infections, however newer iterations of this device are currently being tested to increase its sensitivity.
Isaac I. Bogoch, MD, the lead investigator said, “It was heart-warming to see how well and easily these portable, handheld field microscopes were adopted and used in a rural setting. This will help us map out the areas of greatest need. Novel diagnostic approaches for common parasitic infections could have a profound impact on care of patients, as well as on public health approaches to screening in resource-poor areas.” The study was published on June 27, 2016, in the journal PLOS Neglected Tropical Diseases.
Related Links:
University of Toronto
Newton Microscopes
CellScope
Olympus
Latest Technology News
- Blood Test “Clocks” Predict Start of Alzheimer’s Symptoms
- AI-Powered Biomarker Predicts Liver Cancer Risk
- Robotic Technology Unveiled for Automated Diagnostic Blood Draws
- ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
- Aptamer Biosensor Technology to Transform Virus Detection
- AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
- AI-Generated Sensors Open New Paths for Early Cancer Detection
- Pioneering Blood Test Detects Lung Cancer Using Infrared Imaging
- AI Predicts Colorectal Cancer Survival Using Clinical and Molecular Features
Channels
Clinical Chemistry
view channel
Existing Hospital Analyzers Can Identify Fake Liquid Medical Products
Counterfeit and substandard medicines remain a serious global health threat, with World Health Organization estimates suggesting that 10.5% of medicines in low- and middle-income countries are either fake... Read more
Rapid Blood Testing Method Aids Safer Decision-Making in Drug-Related Emergencies
Acute recreational drug toxicity is a frequent reason for emergency department visits, yet clinicians rarely have access to confirmatory toxicology results in real time. Instead, treatment decisions are... Read moreMolecular Diagnostics
view channel
New Extraction Kit Enables Consistent, Scalable cfDNA Isolation from Multiple Biofluids
Circulating cell-free DNA (cfDNA) found in plasma, serum, urine, and cerebrospinal fluid is typically present at low concentrations and is often highly fragmented, making efficient recovery challenging... Read more
AI-Powered Liquid Biopsy Classifies Pediatric Brain Tumors with High Accuracy
Liquid biopsies offer a noninvasive way to study cancer by analyzing circulating tumor DNA in body fluids. However, in pediatric brain tumors, the small amount of ctDNA in cerebrospinal fluid has limited... Read moreHematology
view channel
Rapid Cartridge-Based Test Aims to Expand Access to Hemoglobin Disorder Diagnosis
Sickle cell disease and beta thalassemia are hemoglobin disorders that often require referral to specialized laboratories for definitive diagnosis, delaying results for patients and clinicians.... Read more
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read moreImmunology
view channel
New Biomarker Predicts Chemotherapy Response in Triple-Negative Breast Cancer
Triple-negative breast cancer is an aggressive form of breast cancer in which patients often show widely varying responses to chemotherapy. Predicting who will benefit from treatment remains challenging,... Read moreBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read morePathology
view channel
Single Sample Classifier Predicts Cancer-Associated Fibroblast Subtypes in Patient Samples
Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest cancers, in part because of its dense tumor microenvironment that influences how tumors grow and respond to treatment.... Read more
New AI-Driven Platform Standardizes Tuberculosis Smear Microscopy Workflow
Sputum smear microscopy remains central to tuberculosis treatment monitoring and follow-up, particularly in high‑burden settings where serial testing is routine. Yet consistent, repeatable bacillary assessment... Read more
AI Tool Uses Blood Biomarkers to Predict Transplant Complications Before Symptoms Appear
Stem cell and bone marrow transplants can be lifesaving, but serious complications may arise months after patients leave the hospital. One of the most dangerous is chronic graft-versus-host disease, in... Read moreTechnology
view channel
Blood Test “Clocks” Predict Start of Alzheimer’s Symptoms
More than 7 million Americans live with Alzheimer’s disease, and related health and long-term care costs are projected to reach nearly USD 400 billion in 2025. The disease has no cure, and symptoms often... Read more
AI-Powered Biomarker Predicts Liver Cancer Risk
Liver cancer, or hepatocellular carcinoma, causes more than 800,000 deaths worldwide each year and often goes undetected until late stages. Even after treatment, recurrence rates reach 70% to 80%, contributing... Read more
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read moreIndustry
view channel
QuidelOrtho Collaborates with Lifotronic to Expand Global Immunoassay Portfolio
QuidelOrtho (San Diego, CA, USA) has entered a long-term strategic supply agreement with Lifotronic Technology (Shenzhen, China) to expand its global immunoassay portfolio and accelerate customer access... Read more







